These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25251920)

  • 21. Current recommendations for monitoring depth of neuromuscular blockade.
    Lien CA; Kopman AF
    Curr Opin Anaesthesiol; 2014 Dec; 27(6):616-22. PubMed ID: 25251919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of routine reversal of neuromuscular blockade on adequacy of recurrent laryngeal nerve stimulation during thyroid surgery.
    Marshall SD; Boden E; Serpell J
    Anaesth Intensive Care; 2015 Jul; 43(4):485-9. PubMed ID: 26099761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
    Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of perioperative muscle strength during ambulatory surgery.
    Alfille PH; Merritt C; Chamberlin NL; Eikermann M
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):730-7. PubMed ID: 19752726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Short acting muscle relaxants: is neuromuscular monitoring still necessary?].
    Blobner M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):348-54; quiz 356, 378. PubMed ID: 19440944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle relaxants suitable for day case surgery.
    Geldner G; Wulf H
    Eur J Anaesthesiol Suppl; 2001; 23():43-6. PubMed ID: 11766246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual neuromuscular blockade: management and impact on postoperative pulmonary outcome.
    Fuchs-Buder T; Nemes R; Schmartz D
    Curr Opin Anaesthesiol; 2016 Dec; 29(6):662-667. PubMed ID: 27755128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Have we learned how to relax our patients, by thinking outside the box?
    Lee C; Katz RL
    J Crit Care; 2009 Mar; 24(1):1-4. PubMed ID: 19272532
    [No Abstract]   [Full Text] [Related]  

  • 29. Sugammadex, the first selective relaxant binding agent for neuromuscular block reversal.
    Stair C; Fernandez-Bustamante A
    Drugs Today (Barc); 2012 Jun; 48(6):405-13. PubMed ID: 22745926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness.
    Brull SJ; Murphy GS
    Anesth Analg; 2010 Jul; 111(1):129-40. PubMed ID: 20442261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuromuscular blockades. Agents, monitoring and antagonism].
    Schreiber JU; Fuchs-Buder T
    Anaesthesist; 2006 Nov; 55(11):1225-35; quiz 1236. PubMed ID: 17082884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities.
    Brull SJ; Kopman AF
    Anesthesiology; 2017 Jan; 126(1):173-190. PubMed ID: 27820709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing sugammadex and neostigmine reversal of neuromuscular blockade in laparoscopic surgery.
    Jain D; Gandhi K
    Anaesthesia; 2013 Mar; 68(3):306-7. PubMed ID: 23384266
    [No Abstract]   [Full Text] [Related]  

  • 34. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period.
    Murphy GS
    Minerva Anestesiol; 2006 Mar; 72(3):97-109. PubMed ID: 16493386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survey of postoperative residual curarization, acute respiratory events and approach of anesthesiologists.
    Aytac I; Postaci A; Aytac B; Sacan O; Alay GH; Celik B; Kahveci K; Dikmen B
    Braz J Anesthesiol; 2016; 66(1):55-62. PubMed ID: 26768931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle relaxants and reversal agents.
    Van Sickel AD; Spadaccia K
    Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How robust are the STRONGER and STIL-STRONGER studies?
    Blobner M; Hunter JM; Ulm K
    Br J Anaesth; 2023 Jan; 130(1):e41-e44. PubMed ID: 36182557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neostigmine vs. sugammadex: observational cohort study comparing the quality of recovery using the Postoperative Quality Recovery Scale.
    Amorim P; Lagarto F; Gomes B; Esteves S; Bismarck J; Rodrigues N; Nogueira M
    Acta Anaesthesiol Scand; 2014 Oct; 58(9):1101-10. PubMed ID: 25179550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of acetylcholinesterase inhibitors on morbidity after general anesthesia and surgery.
    Shay D; Wongtangman K; Eikermann M; Schaefer MS
    Neuropharmacology; 2020 Aug; 173():108134. PubMed ID: 32416089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which muscle relaxants should be used in day surgery and when.
    Bettelli G
    Curr Opin Anaesthesiol; 2006 Dec; 19(6):600-5. PubMed ID: 17093362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.